Persistent BCR::ABL1‐positive preleukemic stem cells drive late clonal evolution in Philadelphia chromosome‐positive ALL

Ítems similars

• Resistance to dasatinib in Philadelphia-positive leukemia patients and the presence or the selection of mutations at residues 315 and 317 in the BCR-ABL kinase domain
  per: Simona Soverini, et al.
  Publicat: (2007-03-01)
• PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOID LEUKEMIA WITH BCR::ABL1 FUSION
  per: MCS Sousa, et al.
  Publicat: (2024-10-01)
• Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis
  per: Simona Soverini, et al.
  Publicat: (2011-04-01)
• Suppression of Philadelphia1 leukemia cell growth in mice by BCR-ABL antisense oligodeoxynucleotide.
  per: Skorski, T, et al.
  Publicat: (1994)
• RAPSYN-mediated neddylation of BCR-ABL alternatively determines the fate of Philadelphia chromosome-positive leukemia
  per: Mengya Zhao, et al.
  Publicat: (2024-06-01)